Canaccord Genuity Maintains Buy on Compass Pathways, Lowers Price Target to $50
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Sumant Kulkarni maintains a 'Buy' rating on Compass Pathways (NASDAQ:CMPS) but lowers the price target from $60 to $50.
August 22, 2023 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Canaccord Genuity maintains a 'Buy' rating on Compass Pathways but lowers the price target from $60 to $50.
The news is directly related to Compass Pathways. While the 'Buy' rating is maintained, the lowering of the price target might indicate a potential decrease in the short-term growth expectation for the company. However, the overall impact is neutral as the 'Buy' rating is still in place.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100